HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
V Torre Selected Research
V Torre Research Topics
Disease
3
Neoplasms (Cancer)
12/2012 - 08/2000
3
Wounds and Injuries (Trauma)
04/2003 - 03/2001
2
Ganglion Cysts (Ganglion)
07/2001 - 08/2000
2
Neoplasm Metastasis (Metastasis)
10/2000 - 08/2000
1
Neurodegenerative Diseases (Neurodegenerative Disease)
01/2002
1
Nervous System Diseases (Neurological Disorders)
07/2001
1
Diabetes Mellitus
03/2001
1
Down Syndrome (Down's Syndrome)
01/2001
1
Syringoma
01/2001
1
Epstein-Barr Virus Infections
10/2000
1
Carcinoma (Carcinomatosis)
10/2000
1
Lymphoma (Lymphomas)
10/2000
1
Paraneoplastic Syndromes (Paraneoplastic Syndrome)
10/2000
1
Tuberculosis (Tuberculoses)
06/2000
1
Laryngitis
06/2000
Drug/Important Bio-Agent (IBA)
3
Proteins (Proteins, Gene)
FDA Link
04/2003 - 03/2001
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
04/2003 - 03/2001
2
Angiogenesis Inducing Agents (Angiogenesis Factor)
IBA
04/2003 - 03/2001
2
Raxofelast
IBA
04/2001 - 03/2001
1
Iodide Peroxidase (Deiodinase)
IBA
12/2012
1
Hormones (Hormone)
IBA
12/2012
1
iodothyronine deiodinase type III (type III deiodinase)
IBA
12/2012
1
Acids
IBA
04/2003
1
Protein Isoforms (Isoforms)
IBA
04/2003
1
Transglutaminases
IBA
01/2002
1
N-Methylaspartate (NMDA)
IBA
07/2001
1
Excitatory Amino Acid Agonists
IBA
07/2001
1
Peroxidase (Myeloperoxidase)
IBA
04/2001
1
Collagen
IBA
04/2001
1
Malondialdehyde (Propanedial)
IBA
04/2001
1
Hypoglycemic Agents (Hypoglycemics)
IBA
03/2001
1
Prednisone (Sone)
FDA Link
Generic
03/2001
1
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
03/2001
1
Messenger RNA (mRNA)
IBA
03/2001
1
Calcium
IBA
01/2001
1
Viral Antigens
IBA
10/2000
1
Keratins (Keratin)
IBA
10/2000
1
Membrane Proteins (Integral Membrane Proteins)
IBA
10/2000
Therapy/Procedure
2
Therapeutics
03/2001 - 08/2000
2
Drug Therapy (Chemotherapy)
10/2000 - 06/2000
1
Electrodes (Electrode)
08/2000
1
Gas Lasers
08/2000